You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction
|
|---|---|
| Published in |
New England Journal of Medicine, September 2014
|
| DOI | 10.1056/nejmoa1405707 |
| Pubmed ID | |
| Authors |
Bo Lagerqvist, Ole Fröbert, Göran K Olivecrona, Thórarinn Gudnason, Michael Maeng, Patrik Alström, Jonas Andersson, Fredrik Calais, Jörg Carlsson, Olov Collste, Matthias Götberg, Peter Hårdhammar, Dan Ioanes, Anders Kallryd, Rickard Linder, Anders Lundin, Jacob Odenstedt, Elmir Omerovic, Verner Puskar, Tim Tödt, Eva Zelleroth, Ollie Östlund, Stefan K James |
| Abstract |
Background Routine intracoronary thrombus aspiration before primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) has not been proved to reduce short-term mortality. We evaluated clinical outcomes at 1 year after thrombus aspiration. Methods We randomly assigned 7244 patients with STEMI to undergo manual thrombus aspiration followed by PCI or to undergo PCI alone, in a registry-based, randomized clinical trial. The primary end point of all-cause mortality at 30 days has been reported previously. Death from any cause at 1 year was a prespecified secondary end point of the trial. Results No patients were lost to follow-up. Death from any cause occurred in 5.3% of the patients (191 of 3621 patients) in the thrombus-aspiration group, as compared with 5.6% (202 of 3623) in the PCI-only group (hazard ratio, 0.94; 95% confidence interval [CI], 0.78 to 1.15; P=0.57). Rehospitalization for myocardial infarction at 1 year occurred in 2.7% and 2.7% of the patients, respectively (hazard ratio, 0.97; 95% CI, 0.73 to 1.28; P=0.81), and stent thrombosis in 0.7% and 0.9%, respectively (hazard ratio, 0.84; 95% CI, 0.50 to 1.40; P=0.51). The composite of death from any cause, rehospitalization for myocardial infarction, or stent thrombosis occurred in 8.0% and 8.5% of the patients, respectively (hazard ratio, 0.94; 95% CI, 0.80 to 1.11; P=0.48). The results were consistent across all the major subgroups, including grade of thrombus burden and coronary flow before PCI. Conclusions Routine thrombus aspiration before PCI in patients with STEMI did not reduce the rate of death from any cause or the composite of death from any cause, rehospitalization for myocardial infarction, or stent thrombosis at 1 year. (Funded by the Swedish Research Council and others; TASTE ClinicalTrials.gov number, NCT01093404 .). |
X Demographics
The data shown below were collected from the profiles of 30 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 17% |
| United Kingdom | 2 | 7% |
| Sweden | 2 | 7% |
| Venezuela, Bolivarian Republic of | 2 | 7% |
| Italy | 1 | 3% |
| Argentina | 1 | 3% |
| Switzerland | 1 | 3% |
| France | 1 | 3% |
| New Zealand | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 13 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 70% |
| Practitioners (doctors, other healthcare professionals) | 7 | 23% |
| Scientists | 2 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | <1% |
| Japan | 2 | <1% |
| Spain | 2 | <1% |
| Netherlands | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 213 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 37 | 17% |
| Researcher | 36 | 16% |
| Student > Ph. D. Student | 27 | 12% |
| Student > Postgraduate | 18 | 8% |
| Student > Master | 13 | 6% |
| Other | 38 | 17% |
| Unknown | 52 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 134 | 61% |
| Agricultural and Biological Sciences | 5 | 2% |
| Nursing and Health Professions | 4 | 2% |
| Engineering | 3 | 1% |
| Psychology | 2 | <1% |
| Other | 9 | 4% |
| Unknown | 64 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 94. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2022.
All research outputs
#447,744
of 25,374,647 outputs
Outputs from New England Journal of Medicine
#6,231
of 32,473 outputs
Outputs of similar age
#4,121
of 248,671 outputs
Outputs of similar age from New England Journal of Medicine
#84
of 289 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,473 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,671 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.